tyrosine and Androgen-Independent Prostatic Cancer

tyrosine has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benassi, E; Chen, Z; Fan, H; Lu, J; Lu, W; Maipas, A; Manarbek, L; Nurkesh, A; Xie, Y; Yang, Q; Yeleussizov, T	1

Other Studies

1 other study(ies) available for tyrosine and Androgen-Independent Prostatic Cancer

Article	Year
Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene, 2019, Volume: 38, Issue:16 Topics: Androgen Antagonists; Androgens; Animals; Carbon; Cell Line, Tumor; Cell Nucleus; Humans; Male; Mice; Mice, Knockout; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-met; PTEN Phosphohydrolase; Signal Transduction; Tyrosine	2019

Article

Year

Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer.

Oncogene, 2019, Volume: 38, Issue:16

Topics: Androgen Antagonists; Androgens; Animals; Carbon; Cell Line, Tumor; Cell Nucleus; Humans; Male; Mice; Mice, Knockout; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-met; PTEN Phosphohydrolase; Signal Transduction; Tyrosine

2019